Call for
GenScript Life Science Research Grant Program
Application Deadline:
15 November 2025
About Organisation
GenScript is a globally recognized biotechnology company dedicated to supporting life science research and innovation. With a robust presence in gene synthesis, peptide synthesis, protein expression, antibody production, and molecular biology services, GenScript serves a wide range of researchers and institutions worldwide. The company has built a strong reputation for delivering high-quality reagents and custom services, driving scientific breakthroughs and accelerating discovery in life sciences. Its commitment to excellence, innovation, and customer satisfaction has established GenScript as a trusted partner for academic, clinical, and industrial researchers alike.
With a focus on providing advanced tools and support to the scientific community, GenScript launched the Life Science Research Grant Program (LSRG Program) as part of its corporate social responsibility and scientific empowerment initiatives. Now in its second year, the LSRG Program reinforces GenScript’s mission to facilitate transformative research that addresses critical challenges in healthcare, diagnostics, and therapeutics. The program is designed to help researchers access cutting-edge reagents and services, enabling them to carry out impactful and novel scientific studies across key disciplines in life sciences. Through such initiatives, GenScript continues to foster collaboration, knowledge advancement, and innovation across borders and scientific fields.
About the Grant
The GenScript Life Science Research Grant Program (LSRG Program) aims to fuel innovation and scientific progress by providing financial support for life science research. Now in its second year, the program is focused on helping researchers access GenScript’s high-quality reagents and services to further their scientific inquiries. The grant initiative is open to applicants working in a broad spectrum of life science fields and is specifically intended to facilitate research in critical focus areas such as gene and cell therapy development, antibody drug discovery, vaccine development, AI-powered drug discovery, and diagnostics.
The LSRG Program offers a range of funding levels, allowing applicants to seek grants from USD 5,000 up to USD 100,000, depending on the nature and scope of their projects. These grants can significantly enhance the capacity of research institutions, biotechnology companies, and individual scientists to pursue innovative studies, develop prototypes, or conduct experimental trials. The selected grantees will receive credits to procure GenScript products and services aligned with their proposed research goals. By supporting groundbreaking research across the globe, this grant reflects GenScript’s unwavering dedication to empowering science and nurturing transformative discoveries that can make a meaningful impact on health and society.
Who can Apply?
The GenScript Life Science Research Grant Program is open to a wide range of global applicants involved in life science research. Eligible participants include legally recognized academic and research institutions, universities, and biotechnology companies that conduct scientific research in areas such as gene and cell therapy, antibody drug discovery, AI-driven drug development, vaccine innovation, and diagnostics.
Applicants must be legally authorized to perform research in their respective jurisdictions and must not be affiliated with any healthcare organizations, including hospitals or healthcare professionals. Employees of GenScript or its affiliated companies, along with their immediate family or household members, are strictly ineligible. Furthermore, any local, state, provincial, or federal government bodies and their employees are also excluded from participation.
Only one application per eligible organization is permitted, and collaborative applications involving multiple entities will not be accepted unless explicitly authorized by GenScript in writing. All applicants must ensure compliance with relevant local, national, and international laws and regulations. The program is open to participants worldwide, except where restricted or prohibited by law. By applying, participants agree to adhere to the program’s terms and conditions, and the decisions made by GenScript regarding eligibility, selection, and disbursement are final and binding.
How to Apply?
Interested applicants should prepare a detailed proposal that aligns with the program’s focus areas, outlining the research objectives and how GenScript products or services will be utilized. The application must be submitted through the designated platform, and only one proposal per organization will be considered. Ensure all eligibility and compliance criteria are met before submitting. Review the full terms and guidelines to enhance your application’s chances of success.
Application Deadline
The GenScript Life Science Research Grant Program is open for submissions until 15 November 2025. Applications received after this date will not be considered for evaluation.
Last Date to Apply
Researchers and institutions must ensure their complete application is submitted by 15 November 2025. Late submissions or incomplete entries will be disqualified from the grant consideration process.
Grant Amount
Applicants can request funding between USD 5,000 and USD 100,000. The final grant amount will be based on the proposed project’s scope, needs, and alignment with GenScript’s focus areas.
Last Date To Apply
For more information, please visit the grant website here.
